James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Despite the Turnaround Effort, Groupon Stock Still Isn’t a Buy

Groupon stock is in the red in the wake of its quarterly earnings report, but GRPN investors may be more worried about something much bigger.

Why Keurig Green Mountain Inc. (GMCR), Viacom, Inc. (VIAB) and Fitbit Inc. (FIT) Are 3 of Today’s Worst Stocks

Keurig Green Mountain (GMCR), Viacom (VIAB) and Fitbit (FIT) battered, beaten, and bruised on Thursday, all thanks to earnings.

What the Heck Does Bill Ackman Want With Mondelez? (MDLZ)

MDLZ shares may not actually be worth more today than they were yesterday, but Bill Ackman is as good of a reason as any to jump on Mondelez.

Tesla Stock: The Honeymoon Is Officially Over (TSLA)

The plunge in Tesla stock following its second-quarter earnings report forces the market to acknowledge that TSLA isn't without its downsides.

Why Sprint Corp. (S), Discovery Communications Inc. (DISCA) and Walt Disney Co. (DIS) Are 3 of Today’s Worst Stocks

Sprint (S), Discovery Communications (DISCA) and Walt Disney (DIS) never even had a chance at a gain on Wednesday. Here's why.

Zillow Stock Is a Buy Despite Lousy Response to Earnings

Zillow stock may not look like much from a valuation standpoint, but give it time -- it's a story stock, and the story is moving forward for the better.

4 Big Pharma Stocks to Own After Q2 Earnings

Big Pharma has a lot to be proud of following some key second-quarter filings and revised full-year outlooks. Four stocks in particular look buy-worthy.

LL Stock: Lumber Liquidators Is Even Worse Than Imagined

LL stock may be in the gutter, but all things considered, that's where it deserves to be. Lumber Liquidators dug itself into a hole it may never fully get out of.

Amazon (AMZN) vs. Netflix (NFLX): Which Highflying Stock Will Face Reality First?

AMZN stock and NFLX stock have a lot of parallels ... on the surface. One of them, however, is up on a wobbly pedestal.

Why Allstate Corp. (ALL), Shire PLC (SHPG) and Norwegian Cruise Line Holdings Ltd (NCLH) Are 3 of Today’s Worst Stocks

Allstate (ALL), Shire (SHPG) and Norwegian Cruise Line Holdings (NCLH) couldn't win for losing on Tuesday. Here's what happened.